However, the MTOR cascade for the inhibition of CRC cell growth also depends on adenosine monophosphate-activated protein kinase (AMPK) activation, which further links cell proliferation with ADIPOQ’s metabolic response, making this interrelation even more complex [31]. Here, ADIPOQ is linked to colorectal carcinoma.